A planning study of proton therapy dose escalation for non-small cell lung cancer.

ABSTRACT: In non-small-cell lung cancer (NSCLC), improving local control through radiotherapy dose escalation might improve survival. However, a photon-based RCT showed increased organ at risk dose exposure and worse overall survival in the dose escalation arm. In this study, intensity-modulated proton therapy plans with dose escalation to the primary tumour were created for 20 NSCLC patients. The mediastinal envelope was delineated to spare structures around the heart. It was possible to increase primary tumour dose up to 74.0 Gy without a significant increase in organ at risk doses and predicted toxicity.

SUBMITTER: Hessels AC 

PROVIDER: S-EPMC11327929 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature